Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,139.83
    +60.97 (+0.75%)
     
  • Bitcoin USD

    64,026.24
    -588.95 (-0.91%)
     
  • CMC Crypto 200

    1,332.11
    -64.42 (-4.61%)
     
  • S&P 500

    5,108.80
    +60.38 (+1.20%)
     
  • Dow

    38,321.49
    +235.69 (+0.62%)
     
  • Nasdaq

    15,944.07
    +332.31 (+2.13%)
     
  • Gold

    2,350.10
    +7.60 (+0.32%)
     
  • Crude Oil

    83.82
    +0.25 (+0.30%)
     
  • 10-Yr Bond

    4.6730
    -0.0330 (-0.70%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Xtandi: A Key Oncology Pillar in 2019

Xtandi: A Key Oncology Pillar in 2019

Pfizer or AstraZeneca: Which Is a Better Pick in April?(Continued from Prior Part)Xtandi’s growth trends According to Pfizer’s (PFE) fourth-quarter earnings conference call, Xtandi is a pillar of the company’s oncology business. In 2018, Pfizer